Stocktoria

Century Therapeutics, Inc. IPSC

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-06-17

Century Therapeutics, Inc. statistics & valuation

Market cap$418.4M
P / S3.8×
P / B2.6×
Net margin-8.8%
Return on equity-6.0%
FCF margin-95.9%
Return on capital-8.5%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-2518.40% -6115.10% -1920.90% -8.80% 202020212022202320242025
Gross margin (%)
202020212022202320242025
Operating margin (%)
-2574.20% -6556.90% -2096.50% -15.80% 202020212022202320242025
Return on equity (%)
-24.20% -43.20% -74.00% -78.40% -6.00% 202020212022202320242025
Shares outstanding
7.5M 58.5M 57.8M 60.3M 85.8M 87.5M 202020212022202320242025
Net debt ($)
-$17.6M -$46.0M -$73.9M 202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-50.20% -21.90% -26.90% -37.90% -35.80% -4.30% 202020212022202320242025
Free cash flow margin (%)
-318.40% -4567.50% -1673.80% -95.90% 202020212022202320242025
Debt / equity (×)
0.03× 0.03× 202020212022202320242025
EPS ($)
-$7.16 -$2.96 -$2.96 -$2.30 -$1.61 -$0.14 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Operating margin-15.8%-2096.5%-6556.9%-2574.2%——
Net margin-8.8%-1920.9%-6115.1%-2518.4%——
FCF margin-95.9%-1673.8%-4567.5%-318.4%——
Return on assets-4.3%-35.8%-37.9%-26.9%-21.9%-50.2%
Return on equity-6.0%-78.4%-74.0%-43.2%-24.2%50.3%
Debt / equity———0.03×0.03×-0.09×
Current ratio5.971.509.9210.7214.576.51

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.